The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.
about
The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The potential of the CMB305 va ...... und cell liposarcoma patients.
@en
The potential of the CMB305 va ...... und cell liposarcoma patients.
@nl
type
label
The potential of the CMB305 va ...... und cell liposarcoma patients.
@en
The potential of the CMB305 va ...... und cell liposarcoma patients.
@nl
prefLabel
The potential of the CMB305 va ...... und cell liposarcoma patients.
@en
The potential of the CMB305 va ...... und cell liposarcoma patients.
@nl
P2860
P1476
The potential of the CMB305 va ...... und cell liposarcoma patients.
@en
P2093
Seth M Pollack
P2860
P304
P356
10.1080/14760584.2018.1419068
P577
2017-12-27T00:00:00Z